AlzeCure Pharma AB (publ) (STO:ALZCUR)
1.470
+0.090 (6.52%)
Apr 30, 2026, 12:06 PM CET
AlzeCure Pharma AB Employees
AlzeCure Pharma AB had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change
-1
Growth
-9.09%
Revenue / Employee
n/a
Profits / Employee
-4.77M SEK
Market Cap
158.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -1 | -9.09% |
| Sep 30, 2025 | 11 | 0 | - |
| Jun 30, 2025 | 11 | 0 | - |
| Mar 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | 0 | - |
| Sep 30, 2024 | 11 | 0 | - |
| Jun 30, 2024 | 11 | 0 | - |
| Mar 31, 2024 | 11 | -1 | -8.33% |
| Dec 31, 2023 | 11 | -2 | -15.38% |
| Sep 30, 2023 | 11 | -3 | -21.43% |
| Jun 30, 2023 | 11 | -3 | -21.43% |
| Mar 31, 2023 | 12 | -2 | -14.29% |
| Dec 31, 2022 | 13 | 1 | 8.33% |
| Sep 30, 2022 | 14 | 2 | 16.67% |
| Jun 30, 2022 | 14 | 3 | 27.27% |
| Mar 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 12 | 3 | 33.33% |
| Sep 30, 2021 | 12 | 4 | 50.00% |
| Jun 30, 2021 | 11 | 3 | 37.50% |
| Mar 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Diamyd Medical AB | 41 |
| IRLAB Therapeutics AB | 31 |
| Xbrane Biopharma AB | 26 |
| NextCell Pharma AB | 24 |
| Alligator Bioscience AB | 13 |
| Xintela AB | 13 |
| Isofol Medical AB | 6 |
| Active Biotech AB | 5 |
AlzeCure Pharma AB News
- 8 months ago - AlzeCure Pharma AB Transcript: Status Update - Transcripts
- 1 year ago - AlzeCure Pharma AB Transcript: Study Update - Transcripts
- 2 years ago - AlzeCure Pharma AB Transcript: Status Update - Transcripts